Buspirone Hydrochloride

CAS 33386-08-2 12 current records 10 historicalSmall Molecule

Who holds supplier records for Buspirone Hydrochloride? 12 organisations hold a current record for Buspirone Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Germany (1), Finland (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Buspirone Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/buspirone-hydrochloride

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Buspirone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Buspirone Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Buspirone Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
EXCELLA GMBH & CO. KG FeuchtDE
CEP 2025-209 - Rev 00
Buspirone hydrochloride
Sept 2026Inspected Apr 2026
Germany
FERMION OY EspooFI
CEP 2021-262 - Rev 01
Buspirone hydrochloride
Jul 2026Inspected Feb 2026
Finland
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2025-096 - Rev 00
Buspirone hydrochloride
Feb 2026—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2024-108 - Rev 00
Buspirone hydrochloride
Sept 2025—
MEDILUX LABORATORIES PRIVATE LIMITED PithampurIN
CEP 2024-322 - Rev 00
Buspirone hydrochloride
Aug 2025Inspected Nov 2025
Germany
MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam VillageIN
CEP 2023-395 - Rev 00
Buspirone hydrochloride
Feb 2025—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2022-151 - Rev 01
Buspirone hydrochloride
Nov 2024—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2021-174 - Rev 01
Buspirone hydrochloride
May 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Buspirone Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • SOUTHWEST SYNTHETIC PHARMACEUTICAL GENERAL FACTORY
    Inactive DMF 15163 · filed Nov 2000
  • Italy · Inactive DMF 12684 · filed Sept 1997
  • Hungary · Inactive DMF 12350 · filed Feb 1997
  • Hungary · Inactive DMF 12172 · filed Oct 1996
  • Spain · Inactive DMF 11469 · filed Apr 1995
  • Italy · Inactive DMF 10414 · filed Aug 1993
  • BIOCHIMICA OPOS 2 SPA
    Inactive DMF 9802 · filed Jul 1992
  • APOTEX PHARMACHEM INC
    Inactive DMF 8928 · filed Jan 1991
  • CYCLO PRODUCTS INC
    Inactive DMF 6418 · filed Jun 1986
  • GANES CHEMICALS INC PENNSVILLE DIV
    Inactive DMF 5397, 4241 · filed May 1984

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Buspirone Hydrochloride is an anxiolytic medication used to treat generalized anxiety disorder. It is known to work on the central nervous system by affecting neurotransmitters, particularly serotonin.

Chemical identity

IUPAC name
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
Canonical SMILES
C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl
InChIKey
RICLFGYGYQXUFH-UHFFFAOYSA-N
Synonyms
BuSpar API, apd-405, apd405, buspar, buspirone hcl, mj 9022-1, mj-9022-1, nsc-751138, nsc-759571

Therapeutic areas

Anxiety DisordersCentral Nervous System

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Buspirone Hydrochloride?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Buspirone Hydrochloride: COHANCE LIFESCIENCES LTD (India), EXCELLA GMBH AND CO KG (Germany), FERMION OY (Finland), Maithri Laboratories Private Limited (India), MEDILUX LABORATORIES PVT LTD (India), SOLARA ACTIVE PHARMA SCIENCES LTD (India), Unichem Laboratories Ltd. (India) and Zydus Lifesciences Limited (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Buspirone Hydrochloride Drug Master Files are active?

COHANCE LIFESCIENCES LTD (DMF 41176), EXCELLA GMBH AND CO KG (DMF 9167), FERMION OY (DMF 11148), Maithri Laboratories Private Limited (DMF 38109), MEDILUX LABORATORIES PVT LTD (DMF 40266), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 35488), Unichem Laboratories Ltd. (DMF 29704) and Zydus Lifesciences Limited (DMF 33431) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Buspirone Hydrochloride records mean?

10 organisations have only inactive Type II DMFs for Buspirone Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Buspirone Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Buspirone Hydrochloride on the EDQM register, including EXCELLA GMBH & CO. KG Feucht (DE), FERMION OY Espoo (FI), COHANCE LIFESCIENCES LIMITED Mumbai (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN) and MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Buspirone Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Buspirone Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.